Jevtana (cabazitaxel) is a prescription cancer medicine that interferes with the growth and spread of cancer cells in the body.
Jevtana is used together with prednisone to treat prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to other parts of the body (metastatic).
Jevtana is usually given when the prostate cancer has worsened (progressed) after being previously treated with other medicines that included docetaxel as part of the treatment.
